Home / Research Library / Characterising long COVID: a living systematic rev...
🧬 Medicine & Biology OpenAlex

Characterising long COVID: a living systematic review

📅 September 1, 2021 👤 Melina Michelen, Lakshmi Manoharan, Natalie Elkheir et al. 📖 BMJ Global Health 📊 975 citations

🤖 Plain-English Summary

Background While it is now apparent clinical sequelae (long COVID) may persist after acute COVID-19, their nature, frequency and aetiology are poorly characterised. There is an urgent need for prospective, robust, standardised, controlled studies into aetiology, risk factors and biomarkers to characterise long COVID in different at-risk populations and settings.

🔑 Key Findings

  • This study aims to regularly synthesise evidence on long COVID characteristics, to help inform clinical management, rehabilitation strategies and interventional studies to improve long-term outcomes.
  • Methods A living systematic review.
  • Medline, CINAHL (EBSCO), Global Health (Ovid), WHO Global Research on COVID-19 database, LitCovid and Google Scholar were searched till 17 March 2021.

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via OpenAlex.

View on DOI ↗

📋 Article Details

Category 🧬 Medicine & Biology
Published Sep 01, 2021
Journal BMJ Global Health
Authors Melina Michelen, Lakshmi Manoharan, Natalie Elkheir, Hung‐Yuan Cheng, Andrew Dagens
DOI 10.1136/bmjgh-2021-005427
Citations 975
Source OpenAlex

More 🧬 Medicine & Biology Research